Leaving No Hole Unclosed: Left Atrial Appendage Occlusion in Patients Having Closure of Patent Foramen Ovale or Atrial Septal Defect

被引:28
作者
Gafoor, Sameer [1 ]
Franke, Jennifer [2 ]
Boehm, Patrick [1 ]
Lam, Simon [1 ]
Bertog, Stefan [1 ,3 ]
Vaskelyte, Laura [1 ]
Hofmann, Ilona [1 ]
Sievert, Horst [1 ]
机构
[1] Cardiovasc Ctr Frankfurt, D-60389 Frankfurt, Germany
[2] Heidelberg Univ, Heidelberg, Germany
[3] Minneapolis Vet Affairs Hosp, Minneapolis, MN USA
关键词
RECURRENT CEREBROVASCULAR EVENTS; CONGENITAL HEART-DISEASE; PERCUTANEOUS CLOSURE; CRYPTOGENIC STROKE; WARFARIN THERAPY; MEDICAL THERAPY; PREVENT STROKE; FIBRILLATION; DEVICE; ECHOCARDIOGRAPHY;
D O I
10.1111/joic.12138
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To report procedural outcome of sequential occlusion of the left atrial appendage (LAA) and an interatrial septal communication and discuss possible indications. Background: There are some patients who may have indications for both closure of patent foramen ovale (PFO) or atrial septal defect (ASD), as well as closure of the LAA. The optimal procedural strategy is not known. Methods: A retrospective review of LAA and PFO/ASD cases at our center was performed. Demographic, echocardiographic, and procedural data were recorded. Results: Closure of LAA and then PFO/ASD (Group I: 11 patients), closure of both in the same setting (Group II: 3 patients), and closure of the PFO/ASD and then the LAA (Group III: 3 patients) was performed in a total of 17 patients. Average age was 63.5 +/- 9.8 years. Most patients were hypertensive with prior cerebrovascular event in 52.9% of patients. Procedural success was 100%. Procedural adverse events were 2 episodes of tamponade (in Group I after first LAA procedure) treated with pericardiocentesis and 1 access-site hematoma (Group II) treated conservatively. Conclusions: Sequential (staged or during the same procedure) closure of the LAA and interatrial communications can be performed safely in a carefully selected patient population. This is also the first known report of LAA occlusion in patients with prior septal closure devices.
引用
收藏
页码:414 / 422
页数:9
相关论文
共 40 条
[1]   Surgical treatment for secundum atrial septal defects in patients >40 years old -: A randomized clinical trial [J].
Attie, F ;
Rosas, M ;
Granados, N ;
Zabal, C ;
Buendía, A ;
Calderón, J .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 38 (07) :2035-2042
[2]   ESC Guidelines for the management of grown-up congenital heart disease (new version 2010) [J].
Baumgartner, Helmut ;
Bonhoeffer, Philipp ;
De Groot, Natasja M. S. ;
de Haan, Fokko ;
Deanfield, John Erik ;
Galie, Nazzareno ;
Gatzoulis, Michael A. ;
Gohlke-Baerwolf, Christa ;
Kaemmerer, Harald ;
Kilner, Philip ;
Meijboom, Folkert ;
Mulder, Barbara J. M. ;
Oechslin, Erwin ;
Oliver, Jose M. ;
Serraf, Alain ;
Szatmari, Andras ;
Thaulow, Erik ;
Vouhe, Pascal R. ;
Walma, Edmond .
EUROPEAN HEART JOURNAL, 2010, 31 (23) :2915-2957
[3]  
Bayard Yves L, 2005, Expert Rev Cardiovasc Ther, V3, P1003, DOI 10.1586/14779072.3.6.1003
[4]   Significant association of atrial vulnerability with atrial septal abnormalities in young patients with ischemic stroke of unknown cause [J].
Berthet, K ;
Lavergne, T ;
Cohen, A ;
Guize, L ;
Bousser, MG ;
Le Heuzey, JY ;
Amarenco, P .
STROKE, 2000, 31 (02) :398-403
[5]   Percutaneous Left Atrial Appendage Occlusion for Patients in Atrial Fibrillation Suboptimal for Warfarin Therapy 5-Year Results of the PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) Study [J].
Block, Peter C. ;
Burstein, Steven ;
Casale, Paul N. ;
Kramer, Paul H. ;
Teirstein, Paul ;
Williams, David O. ;
Reisman, Mark .
JACC-CARDIOVASCULAR INTERVENTIONS, 2009, 2 (07) :594-600
[6]   Stroke recurrence in patients with patent foramen ovale: The Lausanne Study [J].
Bogousslavsky, J ;
Garazi, S ;
Jeanrenaud, X ;
Aebischer, N ;
VanMelle, G .
NEUROLOGY, 1996, 46 (05) :1301-1305
[7]   Warfarin use among patients with atrial fibrillation [J].
Brass, LM ;
Krumholz, HM ;
Scinto, JM ;
Radford, M .
STROKE, 1997, 28 (12) :2382-2389
[8]   Why do patients with atrial fibrillation not receive warfarin? [J].
Bungard, TJ ;
Ghali, WA ;
Teo, KK ;
McAlister, FA ;
Tsuyuki, RT .
ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (01) :41-46
[9]   Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke [J].
Carroll, John D. ;
Saver, Jeffrey L. ;
Thaler, David E. ;
Smalling, Richard W. ;
Berry, Scott ;
MacDonald, Lee A. ;
Marks, David S. ;
Tirschwell, David L. .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (12) :1092-1100
[10]   Transseptal Puncture Through Amplatzer Septal Occluder Device for Catheter Ablation of Atrial Fibrillation: Use of Balloon Dilatation Technique [J].
Chen, Ke ;
Sang, Caihua ;
Dong, Jianzeng ;
Ma, Changsheng .
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2012, 23 (10) :1139-1141